{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:33:24Z","timestamp":1772447604274,"version":"3.50.1"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0139247","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T18:24:49Z","timestamp":1444847089000},"page":"e0139247","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct00556933","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"R. Brian","family":"Stevens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk W.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford D.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre C.","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana F.","family":"Florescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Sandoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore H.","family":"Rigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile E.","family":"Wrenshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1432-2277.2008.00728.x","article-title":"Minimization of steroids in kidney transplantation","volume":"22","author":"AJ Matas","year":"2009","journal-title":"Transpl Int"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"248","author":"ES Woodle","year":"2008","journal-title":"Ann Surg"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1600-6143.2005.00853.x","article-title":"Long-term deterioration of kidney allograft function","volume":"5","author":"BL Kasiske","year":"2005","journal-title":"Am J Transplant"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"M Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"HU Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"S Hariharan","year":"2000","journal-title":"The New England journal of medicine"},{"issue":"24","key":"ref7","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"BJ Nankivell","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin inhibitor nephrotoxicity-lest we forget","volume":"11","author":"JR Chapman","year":"2011","journal-title":"Am J Transplant"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1681\/ASN.2005050463","article-title":"Chronic renal allograft dysfunction","volume":"16","author":"JR Chapman","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/TP.0b013e3182603297","article-title":"Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients","volume":"94","author":"JS Mourer","year":"2012","journal-title":"Transplantation"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10157-010-0269-0","article-title":"Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience","volume":"14","author":"SM Alarrayed","year":"2010","journal-title":"Clin Exp Nephrol"},{"issue":"8104\u20135","key":"ref12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"2","author":"RY Calne","year":"1978","journal-title":"Lancet"},{"issue":"4","key":"ref13","first-page":"486","article-title":"Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients","volume":"153","author":"TE Starzl","year":"1981","journal-title":"Surgery, gynecology & obstetrics"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM198310063091401","article-title":"A randomized clinical trial of cyclosporine in cadaveric renal transplantation","volume":"309","year":"1983","journal-title":"The New England journal of medicine"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"FP Schena","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"SM Flechner","year":"2008","journal-title":"Clin Transplant"},{"key":"ref17","article-title":"A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients","author":"WH Lim","year":"2014","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","article-title":"Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study","volume":"9","author":"Y Lebranchu","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"RS Gaston","journal-title":"Transplantation"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/j.1600-6143.2009.02836.x","article-title":"The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy","volume":"9","author":"A Haririan","year":"2009","journal-title":"Am J Transplant"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"LG Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1600-6143.2009.02555.x","article-title":"Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival","volume":"9","author":"RL Kedainis","year":"2009","journal-title":"Am J Transplant"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"G Einecke","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.tp.0000250492.55775.83","article-title":"Analysis of HLA class I specific antibodies in patients with failed allografts","volume":"83","author":"Q Mao","year":"2007","journal-title":"Transplantation"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","article-title":"Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure","volume":"10","author":"RB Mannon","journal-title":"Am J Transplant"},{"key":"ref26","article-title":"Optimal immunosuppression to prevent chronic allograft dysfunction","author":"JM Grinyo","year":"2010","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11315940-000000000-00000","article-title":"Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology","volume":"70","author":"AO Gaber","year":"2010","journal-title":"Drugs"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/tri.12043","article-title":"Selection of induction therapy in kidney transplantation","volume":"26","author":"KL Hardinger","year":"2013","journal-title":"Transpl Int"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199904150-00013","article-title":"A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients","volume":"67","author":"DC Brennan","year":"1999","journal-title":"Transplantation"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00007890-199807150-00005","article-title":"Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation","volume":"66","author":"AO Gaber","year":"1998","journal-title":"Transplantation"},{"issue":"19","key":"ref31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"DC Brennan","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"16","key":"ref32","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMc0805714","article-title":"Long-term results of rabbit antithymocyte globulin and basiliximab induction","volume":"359","author":"DC Brennan","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1399-0012.2010.01353.x","article-title":"Albuminuria after renal transplantation: maintenance with sirolimus\/low-dose tacrolimus vs. mycophenolate mofetil\/high-dose tacrolimus","volume":"25","author":"CD Miles","year":"2011","journal-title":"Clin Transplant"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.transproceed.2008.10.012","article-title":"Modern approaches to combining sirolimus with calcineurin inhibitors","volume":"40","author":"RB Stevens","year":"2008","journal-title":"Transplantation proceedings"},{"key":"ref35","article-title":"Steroid minimization for sirolimus-treated renal transplant recipients","author":"AJ Matas","journal-title":"Clin Transplant"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11255-009-9601-6","article-title":"Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors","volume":"42","author":"A Srivastava","journal-title":"International urology and nephrology"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1432-2277.2011.01357.x","article-title":"Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials","volume":"24","author":"LH Pengel","year":"2011","journal-title":"Transpl Int"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/TP.0b013e3182551021","article-title":"Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature","volume":"94","author":"B Nashan","year":"2012","journal-title":"Transplantation"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"R Salgo","year":"2010","journal-title":"Am J Transplant"},{"issue":"7","key":"ref40","first-page":"371","article-title":"Transplantation: To convert or not to convert: lessons from the CONVERT trial","volume":"5","author":"S Bunnapradist","year":"2009","journal-title":"Nature reviews"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-0012.2010.01282.x","article-title":"Steroid minimization for sirolimus-treated renal transplant recipients","volume":"25","author":"AJ Matas","year":"2011","journal-title":"Clin Transplant"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/j.1600-6143.2005.01019.x","article-title":"Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus","volume":"5","author":"HU Meier-Kriesche","year":"2005","journal-title":"Am J Transplant"},{"issue":"8","key":"ref43","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1600-6143.2011.03677.x","article-title":"Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice","volume":"11","author":"LK Henderson","year":"2011","journal-title":"Am J Transplant"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/ajkd.2002.36426","article-title":"Protocol biopsies should be part of the routine management of kidney transplant recipients. Con","volume":"40","author":"DR Salomon","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/01.sla.0000137140.79206.d0","article-title":"Long-term immunosuppression, without maintenance prednisone, after kidney transplantation","volume":"240","author":"AJ Matas","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1600-6143.2005.00885.x","article-title":"A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients\u2014an interim analysis","volume":"5","author":"R Kandaswamy","year":"2005","journal-title":"Am J Transplant"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/ajt.12166","article-title":"Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation","volume":"13","author":"TM Suszynski","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"ref48","first-page":"7","article-title":"Improved long-term survival after intra-operative single high-dose ATG-Fresenius induction in renal transplantation: a single centre experience","volume":"14","author":"J Kaden","year":"2009","journal-title":"Ann Transplant"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.tp.0000268084.64888.f3","article-title":"Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety","volume":"84","author":"LE Kyllonen","year":"2007","journal-title":"Transplantation"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jamcollsurg.2004.12.024","article-title":"Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath","volume":"200","author":"R Shapiro","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"9368","key":"ref51","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation","volume":"361","author":"TE Starzl","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/TP.0000000000000250","article-title":"A randomized 2x2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes","volume":"99","author":"RB Stevens","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.1983.188","article-title":"Graft survival after renal transplantation: agenda for analysis","volume":"24","author":"SM Gore","year":"1983","journal-title":"Kidney Int"},{"key":"ref54","first-page":"1057","article-title":"Statistical principles in experimental design","volume":"xiii","author":"BJ Winer","year":"1991"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')","volume":"7","author":"K Solez","year":"2007","journal-title":"Am J Transplant"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1600-6143.2009.02727.x","article-title":"Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts","volume":"9","author":"M Mengel","year":"2009","journal-title":"Am J Transplant"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/TP.0b013e3181722fad","article-title":"Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report","volume":"85","author":"RB Stevens","year":"2008","journal-title":"Transplantation"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1053\/ajkd.2002.32765","article-title":"Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate","volume":"39","author":"J Coresh","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1373\/clinchem.2005.0525144","article-title":"Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program","volume":"52","author":"GL Myers","year":"2006","journal-title":"Clin Chem"},{"key":"ref61","article-title":"Linear Mixed Models for Longitudinal Data","author":"G Verbeke","year":"2009"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1034\/j.1600-6143.2003.00111.x","article-title":"Improved scoring system to assess adult donors for cadaver renal transplantation","volume":"3","author":"SL Nyberg","year":"2003","journal-title":"Am J Transplant"},{"issue":"9","key":"ref63","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/01.tp.0000237101.58974.43","article-title":"Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence","volume":"82","author":"AV Mulay","year":"2006","journal-title":"Transplantation"},{"key":"ref64","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial","author":"MR Weir","journal-title":"Kidney Int"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","article-title":"Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study","volume":"11","author":"Y Lebranchu","year":"2011","journal-title":"Am J Transplant"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/TP.0b013e318208e6d9","article-title":"Steroid avoidance or withdrawal in renal transplantation","volume":"91","author":"SR Knight","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.12015","article-title":"Is it safe to withdraw steroids within seven days of renal transplantation?","volume":"27","author":"X Zhang","year":"2013","journal-title":"Clin Transplant"},{"issue":"8","key":"ref68","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/S0041-1345(98)01322-0","article-title":"Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation","volume":"30","author":"J Kaden","year":"1998","journal-title":"Transplantation proceedings"},{"issue":"1","key":"ref69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1399-0012.2011.01425.x","article-title":"Single-dose rATG induction at renal transplantation: superior renal function and glucoregulation with less hypomagnesemia","volume":"26","author":"RB Stevens","year":"2012","journal-title":"Clin Transplant"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"F Vincenti","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients","volume":"12","author":"F Vincenti","year":"2012","journal-title":"Am J Transplant"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.transproceed.2005.02.075","article-title":"Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters","volume":"37","author":"H Takeuchi","year":"2005","journal-title":"Transplantation proceedings"},{"issue":"3","key":"ref73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-6143.2011.03914.x","article-title":"Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys","volume":"12","author":"JO Pestana","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients","volume":"11","author":"R Ferguson","year":"2011","journal-title":"Am J Transplant"},{"key":"ref75","article-title":"Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors","author":"AD Kirk","year":"2014","journal-title":"Am J Transplant"},{"issue":"4","key":"ref76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology","volume":"78","author":"BJ Nankivell","year":"2004","journal-title":"Transplantation"},{"issue":"8","key":"ref77","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/TP.0b013e3181a079c0","article-title":"Minimizing the risk of chronic allograft nephropathy","volume":"87","author":"MR Weir","year":"2009","journal-title":"Transplantation"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000079390","article-title":"Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function","volume":"24","author":"MR Weir","year":"2004","journal-title":"Am J Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0139247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T20:19:48Z","timestamp":1718137188000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0139247"}},"subtitle":[],"editor":[{"given":"Helge","family":"Bruns","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":78,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0139247","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}